A new subscription-only style payment scheme is set to be trialled by the NHS in order to encourage the development of new antibiotics, Health Secretary Matt Hancock has announced.

In a ‘first-of-its-kind’ payment model, being led by the National Institute for Health and Care Excellence (NICE), NHS England and NHS Improvement will pay pharmaceutical companies upfront for access to medications based on their usefulness to the NHS.